Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib
- DOI
- 10.1182/bloodadvances.2026019704
- Published
- 2026-06-15
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026019704,
title = {Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib},
author = {Blanca De Moner and Julia Martinez-Sanchez and Silvia Escribano-Serrat and Ana Belén Moreno-Castaño and Paola Charry and Joan Cid and Miquel Lozano and Eduardo Arellano-Rodrigo and María Queralt Salas and Montserrat Rovira and Carmen Martínez and Ginés Escolar and Enric Carreras and Alberto Álvarez-Larrán and Maribel Diaz-Ricart},
year = {2026},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2026019704},
url = {https://doi.org/10.1182/bloodadvances.2026019704}
}RIS
TY - JOUR TI - Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib AU - Blanca De Moner AU - Julia Martinez-Sanchez AU - Silvia Escribano-Serrat AU - Ana Belén Moreno-Castaño AU - Paola Charry AU - Joan Cid AU - Miquel Lozano AU - Eduardo Arellano-Rodrigo AU - María Queralt Salas AU - Montserrat Rovira AU - Carmen Martínez AU - Ginés Escolar AU - Enric Carreras AU - Alberto Álvarez-Larrán AU - Maribel Diaz-Ricart PY - 2026 JO - Blood Advances DO - 10.1182/bloodadvances.2026019704 UR - https://doi.org/10.1182/bloodadvances.2026019704 ER -
APA
Moner, B. D., Martinez-Sanchez, J., Escribano-Serrat, S., Moreno-Castaño, A. B., Charry, P., Cid, J., Lozano, M., Arellano-Rodrigo, E., Salas, M. Q., Rovira, M., Martínez, C., Escolar, G., Carreras, E., Álvarez-Larrán, A., & Diaz-Ricart, M. (2026). Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib. Blood Advances. https://doi.org/10.1182/bloodadvances.2026019704
Source records
- crossref · retrieved 2026-09-26T09:44:56.839Z